U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
8148181481Comparing the Expected Benefit of Extra-corporeal-shockwave Therapy (ESWT) Treatment to Standard Care in Treating Diabetic Foot UlcersNot yet recruitingNo Results AvailableDiabetic FootDevice: shock wave therapy|Device: dermagold shockwave|Procedure: standard of carehttps://ClinicalTrials.gov/show/NCT01499472
8148281482Autologous Mesenchymal Stem Cell Transplantation in Liver CirrhosisActive, not recruitingNo Results AvailableLiver CirrhosisGenetic: autologous mesenchymal stem cell transplantationhttps://ClinicalTrials.gov/show/NCT01499459
8148381483A Study of GW685698X 100mcg Administered Once Daily Either in the Morning or the Evening and GW685698X 250mcg Administered Once Daily in the Evening Via DISKHALER for 28 Days in Subjects With Persistent Bronchial Asthma.CompletedNo Results AvailableAsthmaDrug: GW685698X (fluticasone furoate) 100mcg Morning|Drug: GW685698X (fluticasone furoate) 100mcg Evening|Drug: GW685698X (fluticasone furoate) 250mcg Evening|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01499446
8148481484Efficacy and Safety of Caspofungin for Invasive Pulmonary Aspergillosis Underlying Chronic Obstructive Pulmonary DiseaseRecruitingNo Results AvailableInvasive Pulmonary Aspergillosis|Chronic Obstructive Pulmonary DiseaseDrug: caspofunginhttps://ClinicalTrials.gov/show/NCT01499433
8148581485A Single Ascending Dose Study Examining the Safety and Pharmacokinetic Profile of Reconstituted High Density Lipoprotein (CSL112) Administered to PatientsCompletedNo Results AvailableStable Atherothrombotic DiseaseBiological: CSL112 (reconstituted high density lipoprotein)|Biological: Placebohttps://ClinicalTrials.gov/show/NCT01499420
8148681486Randomized Trial of Standard vs ClearWay-infused Abciximab and Thrombectomy for Myocardial InfarctionRecruitingNo Results AvailableST-elevation Myocardial InfarctionDevice: ClearWay RX catheter|Drug: Abciximabhttps://ClinicalTrials.gov/show/NCT01499407
8148781487Caris Biorepository Research ProtocolActive, not recruitingNo Results AvailableCancerhttps://ClinicalTrials.gov/show/NCT01499394
8148881488EMBRACE1: Prostate BiorepositoryCompletedNo Results AvailableProstate Cancerhttps://ClinicalTrials.gov/show/NCT01499381
8148981489A Multi-center, Randomized, Double-blind Phase III Clinical Trial to Assess and Compare to the Efficacy and Safety of Lafutidine, Famotidine and Omeprazole-referenced in Korean Erosive Esophagitis PatientsCompletedNo Results AvailableErosive EsophagitisDrug: Lafutidine|Drug: Famotidine|Drug: Omeprazolehttps://ClinicalTrials.gov/show/NCT01499368
8149081490BIIB023 Proof-of-Concept Study in Participants With Lupus NephritisRecruitingNo Results AvailableLupus NephritisBiological: BIIB023|Biological: Placebo|Drug: Mycophenolate Mofetilhttps://ClinicalTrials.gov/show/NCT01499355
8149181491Belgian Prospective Multicentre Registry to Evaluate Safety and Performance of the Optimed Stent in the Superficial Femoral ArteryCompletedNo Results AvailablePeripheral Arterial Diseasehttps://ClinicalTrials.gov/show/NCT01499342
8149281492Safety and Performance of the Zeus CC Stent for the Treatment of Iliac Occlusive DiseaseRecruitingNo Results AvailablePeripheral Artery Diseasehttps://ClinicalTrials.gov/show/NCT01499329
8149381493Investigating the Effects of Hyperoxia on Fractional Flow ReserveNot yet recruitingNo Results AvailableCoronary Artery DiseaseProcedure: High Flow oxygen|Procedure: Room Airhttps://ClinicalTrials.gov/show/NCT01499316
8149481494Study to Learn if 200mg Test Drug (Fostamatinib) Helps People With Large B-Cell Lymphoma,a Type of Blood CancerCompletedHas ResultsDiffuse Large B-Cell LymphomaDrug: Fostamatinibhttps://ClinicalTrials.gov/show/NCT01499303
8149581495Compare Ceftazidime-Avibactam + Metronidazole Versus Meropenem for Hospitalized Adults With Complicated Intra-Abdominal InfectionsCompletedNo Results AvailableComplicated Intra-Abdominal InfectionDrug: CAZ-AVI|Drug: Metronidazole|Drug: Meropenemhttps://ClinicalTrials.gov/show/NCT01499290
8149681496Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin InfectionsCompletedNo Results AvailableComplicated Skin and Soft Tissue InfectionDrug: Ceftaroline fosamil|Drug: Vancomycin|Drug: Aztreonamhttps://ClinicalTrials.gov/show/NCT01499277
8149781497Efficacy of MySkin Patch for the Healing of Burn Wounds: a Randomised Controlled TrialRecruitingNo Results AvailableBurns|Burn Injury|Hydrogel Bandage|Occlusive DressingsDevice: MySkin patch|Device: Traditional Dressinghttps://ClinicalTrials.gov/show/NCT01499264
8149881498Macitentan in Combo With Dose-dense Temozolomide in Patients With Recurrent GlioblastomaRecruitingNo Results AvailableGlioblastomaDrug: Phase 1 Dose Escalation|Drug: Phase 1b|Drug: Ancillary Studyhttps://ClinicalTrials.gov/show/NCT01499251
8149981499Comparison of Nasal CPAP and Nasal SIMV in Transient Tachypnea of NewbornRecruitingNo Results AvailableTransient Tachypnea of NewbornDevice: Nasal SIMV|Device: nasal CPAPhttps://ClinicalTrials.gov/show/NCT01499238
8150081500A Clinical Trial of YH14642 in Patients With Chronic Periodontal DiseaseCompletedNo Results AvailableChronic PeriodontitisDrug: YH14642 500mg Tab|Drug: YH14642 500mg Tab|Drug: YH14642 500mg Tab|Drug: INSADOL[Zea mays L. extract] 35mg Tab|Drug: DENTISTA[Doxycycline hyclate] 20mg Cap|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01499225
8150181501Effects of Different I:E Ratio on Intrapulmonary Shunt Fraction and Oxygenation During One Lung Ventilation in the Lateral Decubitus PositionCompletedNo Results AvailableLung Cancer|Lung LobectomyProcedure: I:E ratiohttps://ClinicalTrials.gov/show/NCT01499212
8150281502A Study of the Pharmacokinetics and Antiviral Activity of Dolutegravir in the Central Nervous System in HIV-1 Infected ART-naive SubjectsCompletedHas ResultsInfection, Human Immunodeficiency VirusDrug: Dolutegravirhttps://ClinicalTrials.gov/show/NCT01499199
8150381503The Effect of 6 Months of Local Vibration Training in Institutionalized ElderlyCompletedNo Results AvailableOsteoporosis|SarcopeniaOther: Local Vibrationhttps://ClinicalTrials.gov/show/NCT01499186
8150481504A Community Partnership to Treat StrokeRecruitingNo Results AvailableStroke PreparednessBehavioral: Stroke Preparedness Interventionhttps://ClinicalTrials.gov/show/NCT01499173
8150581505GCC 0901 - Study of How Well Letrozole Works in Combination With Lapatinib Followed by an Addition of Everolimus in Postmenopausal Women With Advanced Endocrine Resistant Breast CancerActive, not recruitingNo Results AvailableBreast Neoplasms|Endocrine Breast Diseases|Neoplasm MetastasisDrug: letrozole|Drug: lapatinib|Drug: everolimushttps://ClinicalTrials.gov/show/NCT01499160
8150681506Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic MalignanciesCompletedNo Results AvailableAcute Myeloid Leukemia|Acute Leukemia|Chronic Myelogenous Leukemia|Malignant Lymphoma|Hodgkin's Disease|Multiple Myeloma|Lymphocytic Leukemia|Myeloproliferative Disorder|Polycythemia Vera|Myelofibrosis|Aplastic AnemiaDrug: fludarabine/busulfan|Drug: fludarabine/ melphalanhttps://ClinicalTrials.gov/show/NCT01499147
8150781507Comparison of 2 Beta Blocker Drugs on Peripheral Arterial Disease in Patients With High Blood PressureCompletedHas ResultsPeripheral Artery Disease|HypertensionDrug: nebivolol|Drug: Metoprolol succinatehttps://ClinicalTrials.gov/show/NCT01499134
8150881508Study of Efficacy and Safety of Sunitinib Given on an Individualized ScheduleActive, not recruitingNo Results AvailableClear Cell, Metastatic Renal Cell CarcinomaDrug: Sunitinibhttps://ClinicalTrials.gov/show/NCT01499121
8150981509Time Course of the Blood Pressure Lowering Effect of Liraglutide Therapy in Type 2 DiabetesCompletedNo Results AvailableType 2 DiabetesDrug: liraglutidehttps://ClinicalTrials.gov/show/NCT01499108
8151081510Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Basal Insulin With Oral Antidiabetic TherapyCompletedHas ResultsType 2 Diabetes MellitusDrug: Lantus (Insulin glargine)|Drug: HOE901-U300 (new formulation of insulin glargine)https://ClinicalTrials.gov/show/NCT01499095

* Görseller ve İçerik tekif hakkına sahip olabilir